Cardiomyocytes Deficiency of SENP1 Promotes Myocardial Fibrosis via Paracrine Action
暂无分享,去创建一个
Guanwei Fan | Xiaohui Fan | Sheng Li | Chuanrui Ma | Jingyu Ni | Lan Li | Xiaozhi Liu | Yan-xia Li | Xiaofang Ma | Ying Wang | X. Bian | Yuxiang Wang | Chao Feng | Xiumei Gao | X. Xiao | Dading Lu | Zhihao Liu | Chunyan Zhang | N. Xue | Tian Yu | Li Liu
[1] K. Tanonaka,et al. Involvement of Hsp90 in NLRP3 inflammasome activation in the failing heart following myocardial infarction in rats. , 2023, Biochemical pharmacology.
[2] J. Bargehr,et al. Epicardially secreted fibronectin drives cardiomyocyte maturation in 3D-engineered heart tissues , 2023, Stem cell reports.
[3] Guanwei Fan,et al. SUMO1 regulates post-infarct cardiac repair based on cellular heterogeneity , 2022, Journal of pharmaceutical analysis.
[4] Fang-Yuan Liu,et al. SENP1 Protects Against Pressure Overload‐Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling , 2022, Journal of the American Heart Association.
[5] Sheng Wang,et al. Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma , 2022, Oncogene.
[6] A. Vertegaal. Signalling mechanisms and cellular functions of SUMO , 2022, Nature Reviews Molecular Cell Biology.
[7] Chenying Fu,et al. Signaling pathways and targeted therapy for myocardial infarction , 2022, Signal Transduction and Targeted Therapy.
[8] Jian Hu,et al. DYRK1B-STAT3 Drives Cardiac Hypertrophy and Heart Failure by Impairing Mitochondrial Bioenergetics , 2022, Circulation.
[9] Hyun-Ju Park,et al. A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects , 2022, Theranostics.
[10] A. Orekhov,et al. Heat Shock Protein 90 as Therapeutic Target for CVDs and Heart Ageing , 2022, International journal of molecular sciences.
[11] Juan Li,et al. Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2α-Stat3 pathway in diabetic cardiomyopathy , 2021, Redox biology.
[12] Hongshan Chen,et al. Inhibition of HSP90 S‐nitrosylation alleviates cardiac fibrosis via TGFβ/SMAD3 signalling pathway , 2021, British journal of pharmacology.
[13] Xiangxuan Zhao,et al. The HSP90 inhibitor, XL888, enhanced cell apoptosis via downregulating STAT3 after insufficient radiofrequency ablation in hepatocellular carcinoma. , 2021, Life sciences.
[14] P. Nisticò,et al. Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology , 2021, Journal of experimental & clinical cancer research : CR.
[15] K. Tanonaka,et al. Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice. , 2021, European journal of pharmacology.
[16] M. Giacca,et al. Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner , 2021, Nature Communications.
[17] Dan Liu,et al. Rictor/mTORC2 involves mitochondrial function in ES cells derived cardiomyocytes via mitochondrial Connexin 43 , 2020, Acta Pharmacologica Sinica.
[18] E. Yeh,et al. SUMO: From Bench to Bedside. , 2020, Physiological reviews.
[19] Tian-Le Xu,et al. DUSP6 SUMOylation protects cells from oxidative damage via direct regulation of Drp1 dephosphorylation , 2020, Science Advances.
[20] Xiang Hu,et al. Celastrol Attenuates Angiotensin II–Induced Cardiac Remodeling by Targeting STAT3 , 2020, Circulation research.
[21] M. Donohoe,et al. Yy1 regulates Senp1 contributing to AMPA receptor GluR1 expression following neuronal depolarization , 2019, Journal of Biomedical Science.
[22] Gang Huang,et al. Cardioprotection of post-ischemic moderate ROS against ischemia/reperfusion via STAT3-induced the inhibition of MCU opening , 2019, Basic Research in Cardiology.
[23] Y. Liao,et al. HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis , 2019, Hypertension.
[24] J. Molkentin,et al. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure , 2018, Circulation.
[25] Yuqiang Ding,et al. TRPV1 SUMOylation regulates nociceptive signaling in models of inflammatory pain , 2018, Nature Communications.
[26] L. Kenner,et al. HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3. , 2017, Cellular signalling.
[27] M. Chawla-Sarkar,et al. Myocyte-Derived Hsp90 Modulates Collagen Upregulation via Biphasic Activation of STAT-3 in Fibroblasts during Cardiac Hypertrophy , 2016, Molecular and Cellular Biology.
[28] D. Agard,et al. Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase , 2016, Science.
[29] S. Prabhu,et al. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.
[30] E. Yeh,et al. SUMOylation and SENP3 regulate STAT3 activation in head and neck cancer , 2016, Oncogene.
[31] U. Sohn,et al. SUMO2 overexpression enhances the generation and function of interleukin-17-producing CD8⁺ T cells in mice. , 2015, Cellular signalling.
[32] K. Chan,et al. Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-β1 and collagen synthesis. , 2015, Journal of autoimmunity.
[33] M. Pfreundschuh,et al. Sumoylated HSP90 is a dominantly inherited plasma cell dyscrasias risk factor. , 2015, The Journal of clinical investigation.
[34] S. Xue,et al. SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway. , 2014, Cardiovascular research.
[35] T. Sasada,et al. Human dermal fibroblast migration induced by fibronectin in autocrine and paracrine manners , 2014, Experimental dermatology.
[36] Mark A Sussman,et al. Fibronectin contributes to pathological cardiac hypertrophy but not physiological growth , 2013, Basic Research in Cardiology.
[37] L. Luo,et al. Luteolin Induces Carcinoma Cell Apoptosis through Binding Hsp90 to Suppress Constitutive Activation of STAT3 , 2012, PloS one.
[38] Wolfgang Rottbauer,et al. Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization. , 2012, Genes & development.
[39] J. Buchner,et al. Asymmetric activation of the hsp90 dimer by its cochaperone aha1. , 2010, Molecular cell.
[40] D. Rockey,et al. Fibronectin stimulates endothelin-1 synthesis in rat hepatic myofibroblasts via a Src/ERK-regulated signaling pathway. , 2009, Gastroenterology.
[41] M. Raftery,et al. NSF, Unc-18-1, dynamin-1 and HSP90 are inclusion body components in neuronal intranuclear inclusion disease identified by anti-SUMO-1-immunocapture , 2008, Acta Neuropathologica.
[42] N. D. Clarke,et al. Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells , 2008, Cell.
[43] M. Dasso,et al. Modification in reverse: the SUMO proteases. , 2007, Trends in biochemical sciences.
[44] L. Pearl,et al. Crystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex , 2006, Nature.
[45] G. Rogler,et al. Autocrine Fibronectin-Induced Migration of Human Colonic Fibroblasts , 2004, American Journal of Gastroenterology.